Drug profile · INN
isoetharine mesylate
ISOETHARINE MESYLATE
isoetharine mesylate (ISOETHARINE MESYLATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — isoetharine mesylate
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
isoetharine mesylate (ISOETHARINE MESYLATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is isoetharine mesylate?
isoetharine mesylate (ISOETHARINE MESYLATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for isoetharine mesylate?
ISOETHARINE MESYLATE is a marketed brand name for isoetharine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isoetharine mesylate?
isoetharine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.